These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18392108)

  • 1. 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosis.
    Kornek M; Lukacs-Kornek V; Limmer A; Raskopf E; Becker U; Klöckner M; Sauerbruch T; Schmitz V
    Mol Med; 2008; 14(7-8):365-73. PubMed ID: 18392108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
    Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
    Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.
    Kornek M; Raskopf E; Tolba R; Becker U; Klöckner M; Sauerbruch T; Schmitz V
    Liver Int; 2008 Apr; 28(4):509-18. PubMed ID: 18339078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma.
    Díez S; Navarro G; de ILarduya CT
    J Gene Med; 2009 Jan; 11(1):38-45. PubMed ID: 19021130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
    Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
    Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
    Zou Y; Guo CG; Zhang MM
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
    Liu JY; Chiang T; Liu CH; Chern GG; Lin TT; Gao DY; Chen Y
    Mol Ther; 2015 Nov; 23(11):1772-1782. PubMed ID: 26278330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
    Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
    Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
    Bagi CM; Gebhard DF; Andresen CJ
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted nanoparticles deliver siRNA to melanoma.
    Chen Y; Bathula SR; Yang Q; Huang L
    J Invest Dermatol; 2010 Dec; 130(12):2790-8. PubMed ID: 20686495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
    Han L; Tang C; Yin C
    Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
    Vizio B; Bosco O; David E; Caviglia GP; Abate ML; Schiavello M; Pucci A; Smedile A; Paraluppi G; Romagnoli R; Lupia E; Bellone G; Montrucchio G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice.
    Chen J; Zhu S; Tong L; Li J; Chen F; Han Y; Zhao M; Xiong W
    BMC Cancer; 2014 Feb; 14():114. PubMed ID: 24555445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I.
    Kim SI; Shin D; Choi TH; Lee JC; Cheon GJ; Kim KY; Park M; Kim M
    Mol Ther; 2007 Jun; 15(6):1145-52. PubMed ID: 17440441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
    Liu CH; Chan KM; Chiang T; Liu JY; Chern GG; Hsu FF; Wu YH; Liu YC; Chen Y
    Mol Pharm; 2016 Jul; 13(7):2253-62. PubMed ID: 27224003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma.
    Jia H; Li Y; Zhao T; Li X; Hu J; Yin D; Guo B; Kopecko DJ; Zhao X; Zhang L; Xu DQ
    Cancer Immunol Immunother; 2012 Nov; 61(11):1977-87. PubMed ID: 22527247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma.
    Makita Y; Murata S; Katou Y; Kikuchi K; Uejima H; Teratani M; Hoashi Y; Kenjo E; Matsumoto S; Nogami M; Otake K; Kawamata Y
    Biochem Biophys Res Commun; 2017 Nov; 493(1):800-806. PubMed ID: 28843857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
    Raskopf E; Vogt A; Sauerbruch T; Schmitz V
    J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
    Liu L; Qin S; Zheng Y; Han L; Zhang M; Luo N; Liu Z; Gu N; Gu X; Yin X
    Cancer Biol Ther; 2017 Mar; 18(3):166-176. PubMed ID: 28368741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells.
    Younis MA; Khalil IA; Abd Elwakil MM; Harashima H
    Mol Pharm; 2019 Sep; 16(9):4031-4044. PubMed ID: 31403802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.